The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of Ligand Binding Hot Spots of the Histamine HEBI
Vrije Universiteit Amsterdam
A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.EBI
Vrije Universiteit Amsterdam
Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.EBI
Vrije Universiteit Amsterdam
Linking agonist binding to histamine H1 receptor activation.EBI
Vrije Universiteit Amsterdam
Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.EBI
Vrije Universiteit Amsterdam
Development of EBI
Vrije Universiteit Amsterdam
Structural Analysis of Chemokine Receptor-Ligand Interactions.EBI
Vrije Universiteit Amsterdam
Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.EBI
Vrije Universiteit Amsterdam
Fragment-to-Lead Medicinal Chemistry Publications in 2020.EBI
Vrije Universiteit Amsterdam
Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists.EBI
Vrije Universiteit Amsterdam
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.EBI
Vrije Universiteit Amsterdam
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine HEBI
Vrije Universiteit Amsterdam
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).EBI
Vrije Universiteit Amsterdam
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors.EBI
Vrije Universiteit Amsterdam
Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.EBI
Vrije Universiteit Amsterdam
Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.EBI
Vrije Universiteit Amsterdam
N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.EBI
Vrije Universiteit Amsterdam
Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.EBI
Vrije Universiteit Amsterdam
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.EBI
Vrije Universiteit Amsterdam
Trifluoromethyl alcohols as modulators of RORγtBDB
Janssen Pharmaceutica